SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The meme coin "crow with knife" ($CAW) is gaining attention, with community members highlighting its deflationary mechanism and presence across multiple chains like Solana, BSC, CRO, and ETH.  Enthusiasts are also excited about potential staking opportunities and partnerships. Community buzz is focused on its organic growth and strong "cult" following.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses potential catalysts and its broader ecosystem. Conversations highlight the emergence of new meme coins built on Solana, like $SOLYCAT and $CAW, while others focus on staking opportunities. There is also bullish sentiment around its long-term potential and increasing institutional interest as Fidelity now offers Solana.

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is trending as a new Solana-based meme token, generating buzz around its recent launch and availability on Phantom Wallet. The community is drawn to its potential for high gains, with many emphasizing its momentum within the Solana ecosystem alongside established tokens. Conversations highlight its strong chart and potential breakout.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending as the community discusses its recent price action and potential. Some traders are pointing to listing on Robinhood as a catalyst, while others debate whether it's a pump and dump, but many bulls see strong potential due to the project's focus on AI and development of AI agents. Discussion includes the ecosystem utility and agents like G.A.M.E, which are gaining traction.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USD Coin is trending as discussions swirl around stablecoin regulation and its potential role in the evolving financial landscape. Community members are weighing in on its stability, integration with various platforms like Solana, and comparisons to other stablecoins like USDT.  Additionally, its adoption in decentralized finance (DeFi) and real-world applications, like cross-border payments and tokenized assets, are being closely monitored.

Ambarella, Inc. engages in the development of low-power system-on-a-chip, or SoC, semiconductors and software for edge artificial intelligence, or AI, applications. Its products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. The firm's geographical segments include Taiwan, Asia Pacific, Europe, North America other than United States and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella is trending after surprising investors with strong guidance and Q2 results, driven by AI-powered edge processing. Community members are actively discussing the company's potential for growth in the drone, automotive, and robotics sectors, along with speculation regarding a potential buyout. Some traders are also pointing to the stock's technical setup and low float, suggesting it could be primed for further upside.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin is trending as the community discusses its potential, partnerships, and possible ETF. A segment of the community is focused on the token's multi-chain presence through projects like $CAW. Others express frustration with price action, debating whether to buy and stake or take profits.

WISeKey International Holding Ltd. is a cybersecurity company, which engages in offering digital security technology solutions. The firm operates through the Internet of Things (IoT), and Managed Public Key Infrastructure (mPKI) segments. The IoT segment refers to the design, manufacturing, sales and distribution of microprocessors operations. The mPKI segment includes all operations relating to the provision of secured access keys, authentication, signing software, certificates and digital security applications. The company was founded by Joao Carlos Creus Moreira and Philippe Doubre in 1999 and is headquartered in Zug, Switzerland.

WISeKey International Holding Ltd - ADR

WISeKey is trending as investors discuss its potential upside in the post-quantum computing era, particularly in securing satellite constellations. The community is highlighting the company's subsidiaries, including SEALCOIN and WISeSat, and comparing its market cap to its parent company, LAES.  Some investors believe WKEY's current valuation doesn't reflect the value of its assets and potential growth in the quantum security market.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending as the community discusses the company's recent acquisition of Astria Therapeutics, a move aimed at strengthening its position in the hereditary angioedema (HAE) market. While some investors express concerns about potential dilution and debt, others view the acquisition as a strategic move to capture a larger share of the HAE market by offering both oral and injectable treatments. The community is actively debating the long-term benefits and risks associated with this expansion strategy within the competitive biotech landscape.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as community members discuss potential growth catalysts, including AI and automotive applications, despite recent earnings news. Some traders are pointing to technical indicators suggesting a possible short-term breakout, while others express frustration with the stock's performance relative to its peers. Community sentiment appears mixed as some see a buying opportunity, while others remain bearish.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates

AMN Healthcare (AMN) delivered earnings and revenue surprises of +76.47% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Healthcare technology firm Aclarion Inc.'s (ACON) stock surged nearly 127% on Monday, marking its best single-day gain since going public in 2022.&nbsp;The surge followed news that Aclarion has entered into a commercial agreement with Scripps Health, bringing its Nociscan technology — a noninvasive tool that helps physicians personalize treatment for chronic lower back pain — to Scripps' network of doctors in San Diego, California.Aclarion says the deal will allow Scripps physicians to better differentiate between painful and non-painful lumbar discs using magnetic resonance spectroscopy and advanced signal processing.&nbsp;While the partnership's financial terms were not disclosed, the news generated widespread enthusiasm among retail traders, driving a dramatic surge in trading activity and online discussions.Investor chatter on Stocktwits turned sharply bullish in response to the announcement. The company's follower count on the platform jumped nearly 20%, while message volume surged by over 6,000% by the end of Monday's session.A Stocktwits poll found that 41% of more than 1,100 retail traders view the partnership as a "game-changer," while 32% describe it as "short-term hype, long-term unknown." The remaining see it as a "liquidity event" or too early to make a definitive judgment.Retail traders debated the deal's broader implications, with one suggesting that it could make Aclarion a potential acquisition target for major medical technology firms.&nbsp;One user speculated that a buyout by a company like Medtronic could send the stock significantly higher, while another dismissed concerns about potential dilution, predicting a run to $10–$20.<stembedurl>https://stocktwits.com/TraderMitsos/message/606583790</stembedurl><stembedurl>https://stocktwits.com/Hotoilguy/message/606598370</stembedurl>Aclarion, which has a market capitalization of just $7.7 million, remains an early-stage company that has yet to generate revenue.&nbsp;Short interest on the stock has jumped from 11.8% at the start of 2025 to 24.2% by the end of last week, according to Koyfin.Following Monday's rally, <a href="https://stocktwits.com/symbol/ACON">Aclarion shares</a> are now up over 5% year-to-date. According to Koyfin data, only two analysts currently cover Aclarion, with one rating it a 'Buy' and the other a 'Hold.'The stock was seeing heavy profit-taking in Monday's after-hours trading, falling over 14%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Is Aclarion's Tie-Up With Scripps Health A Lasting Catalyst? Most Retail Traders Think It's A 'Game-Changer'

The company's follower count on Stocktwits jumped nearly 20%, while message volume surged by over 6,000% by the end of Monday's session.

Equity

The company's follower count on Stocktwits jumped nearly 20%, while message volume surged by over 6,000% by the end of Monday's session.


Aclarion Inc. shares surged 94% on Thursday afternoon in heavy trading after the healthcare technology company executed a 1-for-335 reverse stock split.&nbsp;The move reduced its outstanding common shares from approximately 169.4 million pre-split to around 500,000 post-split.The reverse split propelled Aclarion to the top of Stocktwits’ trending tickers, with its retail following jumping 59% from Wednesday’s close.&nbsp;Bullish traders speculated the stock could climb another 45% from current levels, while some anticipated a near-tripling.<stembedurl>https://stocktwits.com/GreenReaperx/message/602177528</stembedurl><stembedurl>https://stocktwits.com/SCNC/message/602177417</stembedurl>Aclarion specializes in Magnetic Resonance Spectroscopy (MRS) and augmented intelligence algorithms to help physicians pinpoint sources of chronic low back pain through its SaaS platform, Nociscan.&nbsp;Earlier this month, the stock received a boost after the company announced it had terminated an agreement with Ascendiant Capital for a $10 million at-the-market share offering.&nbsp;According to a regulatory filing, Aclarion raised about $300,000 in gross proceeds before canceling the deal, which was initiated in September 2024.Despite losing&nbsp;over 71% of its value over the past three months, Aclarion’s retail following on Stocktwits has surged 50%, with message volume soaring over 6,000%.Aclarion’s stock last had a short interest of 17.4%, according to Koyfin data.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a stock chart | Image source: Maria Korneeva on Getty Images

Aclarion’s Retail Following Jumps 60% After Reverse Stock Split As Micro-Cap Health Tech Shares Nearly Double

Earlier this month, the stock received a boost after the company announced it had terminated an agreement with Ascendiant Capital for a $10 million at-the-market share offering.

Analysts Offer Insights on Healthcare Companies: Aclarion, Inc. (ACON), Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aclarion, Inc. (ACON Research Report), Edwards Lifesciences (EW...

Aclarion, Inc. (NASDAQ:ACON) Sees Large Increase in Short Interest

Aclarion, Inc. (NASDAQ:ACON  Get Free Report) saw a significant growth in short interest during the month of February. As of February 29th, there was short interest totalling 159,100 shares...

Aclarion announces publication of peer-reviewed data in journal on lumbar discs

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs

Confirms predictive value of Nociscan for identifying painful discs. Nociscan demonstrated a sensitivity of 100% and a specificity of 80% compared to provocative discography (PD), suggesting...

Aclarion Announces Closing of $3.0 Million Public Offering

BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. ( Aclarion or the Company ) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...

Aclarion Announces Pricing of $3.0 Million Public Offering

BROOMFIELD, CO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. ( Aclarion or the Company ) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Company is initiating its pivotal multicenter, prospective, randomized CLARITY trial to build on clinical evidence demonstrating superior surgical outcomes when Nociscan is utilized in surgical...

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	0.00%
50-Day Moving Average	$7.75
Beta	1.84
Avg. Volume	16,961.10
PE Ratio	0.00

52-Week High	$3,499.51
52-Week Low	$6.20
Market Capitalization	$4.88M
EPS (Annual)	-$7,480.22
Price to Book	0.31
Revenue Per Employee	$7,620.67
Enterprise Value/EBITDA	N/A

ACON
Aclarion Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ACON News

ACONAclarion Inc